An Experimental RSV Vaccine For Pregnant Women From Pfizer

Pfizer Develops RSV Vaccine for Pregnant Women to Immunize their Unborn Babies While in the Womb

Pfizer claims that their infants will be protected against the respiratory syncytial virus (RSV) after birth.

In the Pfizer study, 7,400 pregnant women were randomly assigned to receive a single dosage of RSVpreF or a placebo during the late second to the third trimester of their pregnancy.

Just like with Covid, RSV has an extremely low mortality rate. But, the science says we need another experimental vaccine – “Trust the Science” has always been about ulterior motives